Uses of undefined

Darolutamide is used to treat non-metastatic, castration-resistant prostate cancer (prostate cancer that hasn’t spread to other body parts and does not respond to surgical treatment). It is also indicated to treat hormone-sensitive metastatic prostate cancer (cancer that spreads to other parts of the body) in combination with other anticancer medications.

undefined Drug administaration and Dosage available

Darolutamide is available as an oral tablet. It is a prescription medicine. The tablet should be taken exactly as prescribed by your healthcare provider. Swallow this medication whole with water. It can be taken with food. Do not break, crush, or chew the tablet. Your doctor will decide the frequency of the tablet based on your disease severity and other factors. 

Warnings, Precautions and Side Effects of undefined

Warnings

Risk of ischemic heart disease is high in patients receiving this medication regularly. Regular monitoring of signs and symptoms of heart attack is necessary. Report symptoms of chest pain, pain in arms, jaw pain, and shoulder pain immediately. Darolutamide is not indicated for women, especially if they are pregnant, because it causes severe birth defects in the baby. Inform your physician if you have seizures, lung disorders, kidney problems, or heart problems, including changes in heart rhythm and hypertension, before starting the treatment with this medicine.  

Precautions

Inform your physician about all the prescription medicines, over-the-counter medicines, nutritional or vitamin supplements, nasal flu vaccine, and herbal products that you are currently taking or have taken before. It is advised to use contraceptives if you have a female partner with reproducing ability. Use contraceptives during the treatment and for 1 week after the last dose. If you come into contact with this medicine and are pregnant or breastfeeding, it is advisable to discuss it with your physician. Your healthcare professional may advise you to take certain blood tests to monitor the effectiveness and side effects of the therapy. 

Side Effects

The common side effects of darolutamide are fatigue, rash, muscle pain, bone pain, pain in the arms and legs, and broken bones. Serious side effects include chest pain, pain in arms, jaw, neck, and back, lightheadedness or dizziness, shortness of breath, swelling of ankles and legs, and seizures. Even though all medicines have side effects, not everyone gets them. 

Word Of Advice

Do not take this medicine if you are allergic to darolutamide or any other ingredient in it. This medicine should be taken with food. Inform your physician if you are facing any symptoms of seizures, swelling in your legs, ankle, and face, abdominal pain, shortness of breath, and chest pain after taking this medicine. Notify your physician if you are taking any antibiotics, cholesterol medications, and other prescribed medicines. Darolutamide is not indicated in children and adolescents less than 18 years of age. Pregnant and breastfeeding women should not consume this medication since this is used to treat prostate cancer.   

Frequently Asked Question

• What happens when women consume darolutamide unknowingly?
• Darolutamide is not indicated for women. If the medicine has been taken unknowingly, inform your doctor immediately and seek medical advice.

• What is the Darolutamide package insert?
• The FDA provides a package insert, which summarizes the relevant scientific information needed for healthcare practitioners and patients to use the drug safely and effectively. The  Darolutamide package insert contains safety information, instruction for use, and other information.

• Can Darolutamide be crushed?
• Do not break, crush or chew the tablet. Darolutamide should be taken with food. Take the tablet as a whole with water.

• Will Darolutamide lower prostate-specific antigen?
• yes, Darolutamide lowers PSA levels and it prevents cancer from spreading to other parts of the body.

• What is the use of Darolutamide?
• It is used to treat patients having hormone-sensitive non-metastatic, castration-resistant prostate cancer (prostate cancer that hasn’t spread to other body parts and does not respond to medicinal or surgical treatment) in combination with other anti-cancer medication.